Format
Sort by

Send to:

Choose Destination

Links from PubChem BioAssay

Items: 5

1.

Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells.

Chen J, Dexheimer TS, Ai Y, Liang Q, Villamil MA, Inglese J, Maloney DJ, Jadhav A, Simeonov A, Zhuang Z.

Chem Biol. 2011 Nov 23;18(11):1390-400. doi: 10.1016/j.chembiol.2011.08.014.

2.

The ubiquitin-specific protease USP28 is required for MYC stability.

Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R, Moll R, Elledge SJ, Eilers M.

Nat Cell Biol. 2007 Jul;9(7):765-74. Epub 2007 Jun 10.

PMID:
17558397
3.

The isopeptidase USP2a protects human prostate cancer from apoptosis.

Priolo C, Tang D, Brahamandan M, Benassi B, Sicinska E, Ogino S, Farsetti A, Porrello A, Finn S, Zimmermann J, Febbo P, Loda M.

Cancer Res. 2006 Sep 1;66(17):8625-32.

4.

A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia.

De Pittà C, Tombolan L, Campo Dell'Orto M, Accordi B, te Kronnie G, Romualdi C, Vitulo N, Basso G, Lanfranchi G.

Haematologica. 2005 Jul;90(7):890-8.

5.

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, Courtois G.

Nature. 2003 Aug 14;424(6950):801-5.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk